ABSTRACT
BACKGROUND: Intense pain can last several days after tonsillectomy. It is often undertreated and improved analgesic strategies that can be safely used at home are needed. METHODS: We conducted a systematic review and meta-analysis on the effectiveness of systemic medications used for post-tonsillectomy pain in adult and adolescent (13 yr old) patients. Studies were identified from PubMed, the Cochrane Library, and by hand searching reference lists from studies and review articles. Randomised, double-blind, placebo-controlled studies reporting on pain intensity or use of rescue analgesia were included. RESULTS: Twenty-nine randomised controlled trials representing 1816 subjects met the inclusion criteria. Follow-up time was ≤24 h in 15 studies, in which the majority were taking nonsteroidal anti-inflammatory drugs. Thirteen studies were suitable for meta-analysis. In pooled analysis, paracetamol, dexamethasone, and gabapentinoids reduced pain intensity on the day of operation. In individual studies, ketoprofen, ibuprofen, lornoxicam, parecoxib, rofecoxib, indomethacin and dextromethorphan reduced pain intensity, need for rescue analgesics, or both on the day of operation. Oral celecoxib for 2 postoperative weeks or i.v. ketamine on the day of operation were not effective at the studied doses. Dexamethasone in multiple doses provided analgesia beyond 1 postoperative day. Pain was moderate to strong in both study and control groups during the first postoperative week. CONCLUSIONS: Single analgesics and dexamethasone provide only a weak to moderate effect for post-tonsillectomy pain on the day of operation and thus a multimodal analgesic strategy is recommended. Short follow-up times and clinical heterogeneity of studies limit the usefulness of results.
Subject(s)
Analgesics/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Dexamethasone/therapeutic use , Pain, Postoperative/drug therapy , Tonsillectomy , Adult , HumansABSTRACT
OBJECTIVES: In order to evaluate the safety of tonsillectomy among children, we retrospectively studied the incidence of post-operative complications, adverse events and their association with peri-operative medication. METHODS: Data were collected from the medical records of 691 patients aged 1-16 years, including details of post-operative complications (any unplanned contact with the hospital), analgesics, dexamethasone, 5-HT3 antagonists, local anaesthetic and haemostatic agents. RESULTS: Recovery was complicated in 13.6 per cent of patients, of whom 8.4 per cent were re-admitted to the ward. The most common complication was post-tonsillectomy haemorrhage, experienced by 7.1 per cent of patients. Re-operation under general anaesthesia (for grade III post-tonsillectomy haemorrhage) was required by 4.2 per cent of patients. Peritonsillar infiltration of lidocaine with adrenaline increased the risk of post-tonsillectomy haemorrhage (odds ratio = 4.1; 95 per cent confidence interval = 2.1 to 8.3). CONCLUSION: Every seventh paediatric patient experienced a complicated recovery after tonsillectomy, caused by post-tonsillectomy haemorrhage in most cases. Local peritonsillar infiltration of lidocaine with adrenaline was associated with an increased risk of post-tonsillectomy haemorrhage.
Subject(s)
Anesthetics, Local/adverse effects , Epinephrine/adverse effects , Lidocaine/adverse effects , Postoperative Hemorrhage/etiology , Tonsillectomy/adverse effects , Adolescent , Child , Child, Preschool , Epinephrine/administration & dosage , Female , Finland/epidemiology , Humans , Incidence , Infant , Lidocaine/administration & dosage , Male , Postoperative Hemorrhage/epidemiology , Reoperation/statistics & numerical data , Retrospective Studies , Tonsillectomy/methods , Tonsillectomy/statistics & numerical data , Treatment OutcomeABSTRACT
The key stakeholders of the Finnish engineering education collaborated during 2006-09 to reform the system of education, to face the challenges of the changing business environment and to create a national strategy for the Finnish engineering education. The work process was carried out using participatory work methods. Impacts of sustainable development (SD) on engineering education were analysed in one of the subprojects. In addition to participatory workshops, the core part of the work on SD consisted of a research with more than 60 interviews and an extensive literature survey. This paper discusses the results of the research and the work process of the Collaboration Group in the subproject of SD. It is suggested that enhancing systematic dialogue among key stakeholders using participatory work methods is crucial in increasing motivation and commitment in incorporating SD in engineering education. Development of the context of learning is essential for improving skills of engineering graduates in some of the key abilities related to SD: systemic- and life-cycle thinking, ethical understanding, collaborative learning and critical reflection skills. This requires changing of the educational paradigm from teacher-centred to learner-centred applying problem- and project-oriented active learning methods.
Subject(s)
Conservation of Natural Resources , Cooperative Behavior , Engineering/education , Problem-Based Learning , Teaching/methods , Comprehension , Finland , Humans , Interviews as Topic , ThinkingSubject(s)
Checklist , Health Knowledge, Attitudes, Practice , Otolaryngology/standards , Otorhinolaryngologic Diseases/surgery , Otorhinolaryngologic Surgical Procedures/standards , Patient Safety/standards , Safety Management/methods , World Health Organization , Anesthesiology/standards , Female , Finland , Guideline Adherence , Humans , Male , Operating Rooms/standards , Surveys and QuestionnairesABSTRACT
BACKGROUND: World Health Organisation (WHO) has introduced a surgical safety checklist that has reduced post-operative morbidity and mortality. Prior to national checklist implementation, we assessed its possible impact on the operating room (OR) process, safety-related issues and communication among surgical staff in a high-income country. METHODS: In four university and teaching hospitals, a structured questionnaire was delivered to OR personnel involved in consecutive operations over 4-6 weeks before and after the checklist implementation. The questionnaire resembled the WHO checklist and comprised multiple-choice questions relating to performance of safety checks and communication. Anaesthesiologists (A), surgeons (S) and circulating nurses (CN) answered the questions independently. The WHO checklist was modified for national needs. RESULTS: Questionnaires were returned from 1748 operations, 901 before and 847 after the checklist. Patient's identity was more often confirmed (A: 62.7% vs. 84.0%, S: 71.6% vs. 85.5%, CN: 81.6% vs. 94.2%, P < 0.001) and knowledge of names and roles among team members (A: 65.7% vs. 81.8%, S: 71.1% vs. 83.6%, CN: 87.7% vs. 93.2%, P < 0.01) improved with the checklist. Anaesthesiologists and surgeons discussed critical events pre-operatively (A: 22.0% vs. 42.6%, S: 34.7% vs. 46.2%, P < 0.001) more frequently after the checklist. In addition, fewer communication failures (43 vs. 17, P < 0.05) were reported with checklist. CONCLUSIONS: The checklist increased OR teams' awareness of patient-related issues, the procedure and expected risks. It also enhanced team communication and prevented communication failures. Our findings support use of the WHO checklist in various surgical fields.
Subject(s)
Checklist/methods , Surgical Procedures, Operative/methods , Anesthesiology , Antibiotic Prophylaxis/statistics & numerical data , Checklist/statistics & numerical data , Communication , Finland , General Surgery , Health Care Surveys , Humans , Nurses , Operating Rooms/organization & administration , Patient Care Team , Patient Safety , Physicians , Pilot Projects , Postoperative Care/standards , Prospective Studies , Reproducibility of Results , Surgical Procedures, Operative/statistics & numerical data , Surveys and Questionnaires , Task Performance and Analysis , World Health OrganizationABSTRACT
OBJECTIVES: The World Health Organisation has developed a Surgical Safety Checklist to improve patient safety during surgery. This checklist has reduced postoperative morbidity and mortality. Prior to checklist implementation, we wanted to evaluate how it would fit into the process of otorhinolaryngology-head and neck surgery and whether it would have an impact on the awareness of safety-related issues. DESIGN: A structured questionnaire was addressed to the operating room team after consecutive operations during a 1-month period before and after checklist implementation. SETTING AND PARTICIPANTS: This study was conducted at the Department of Otorhinolaryngology at the Helsinki University Central Hospital as a part of a multicentre study. Responses were received regarding 288 operations before and 412 after checklist implementation. MAIN OUTCOME MEASURES: The questions concerned patient-related safety checks, teamwork and communication. RESULTS: The checklist improved verification of the patient's identity (P<0.001). Awareness of the patient's medical history, medication and allergies increased (P<0.001). Knowledge of the names and roles among the team members improved. The otolaryngologists and anaesthesiologists discussed possible critical events more often (P<0.001), and postoperative instructions were better recorded after use of the checklist. In addition, the checklist enhanced communication between operation team members. CONCLUSIONS: Our study confirms that the Surgical Safety Checklist fits well into the surgical working process in otorhinolaryngology-head and neck surgery improving the sharing of patient-related medical information between team members. Development of a specific checklist for otolaryngology calls for further study.
Subject(s)
Checklist , Operating Rooms/standards , Otolaryngology/standards , Otorhinolaryngologic Diseases/surgery , Otorhinolaryngologic Surgical Procedures/standards , Patient Safety/standards , Safety Management/methods , Adolescent , Child , Child, Preschool , Finland , Humans , Infant , Infant, Newborn , Pilot Projects , Retrospective Studies , World Health OrganizationABSTRACT
GOALS OF WORK: No blood marker available to date is useful for distinguishing infection-related from neoplasm-related fever. We evaluated the expression of the peripheral blood phagocyte CD11b/CD18 adhesion molecule complex for this purpose. MATERIALS AND METHODS: Neutrophil and monocyte CD11b/CD18 expression was assessed in two cohorts of patients with advanced solid cancer (n = 120) and in healthy controls (n = 63). The cancer series included 89 patients with verified infection, 23 without infection, and eight with neoplastic fever. CD11b/CD18 expression was measured using flow cytometry, and serum C-reactive protein (CRP) concentration was determined with immunoturbidimetric assay. RESULTS: Cancer patients with infection had higher blood neutrophil and monocyte CD11b/CD18 expression levels than patients with neoplastic fever, those with advanced cancer without infection, or healthy controls (p < 0.01 for all analyses). High CD11b/CD18 values were measured exclusively in individuals diagnosed with infection. Receiver-operating characteristic area under the curve (AUC) for neutrophil and monocyte CD11b/CD18 expression for the discrimination of infection from neoplastic fever was 0.80 (95% CI, 0.70 to 0.88), which was superior (p = 0.039 and p = 0.049, respectively) to serum CRP on admission (AUC 0.51, 0.40 to 0.62). CONCLUSIONS: Peripheral blood phagocytic cell CD11b/CD18 expression is useful for making a differential diagnosis between infection and neoplasm-related fever in cancer patients.
Subject(s)
CD11b Antigen/metabolism , CD18 Antigens/metabolism , Infections/diagnosis , Neoplasms/complications , Adult , Aged , Case-Control Studies , Cell Adhesion , Female , Flow Cytometry , Humans , Infections/complications , Male , Middle Aged , Monocytes/metabolism , Neutrophils/metabolism , Predictive Value of Tests , ROC Curve , Up-RegulationABSTRACT
OBJECTIVE AND DESIGN: Prognostic value of markers of systemic inflammation were evaluated in patients admitted to hospital. MATERIAL: The study comprises 327 patients with community- acquired infection verified on admission (n=290) or within 3-day follow-up (n=37). METHODS: On-admission levels of phagocyte CD11b/CD18 and CD14 expression were measured using whole blood flow cytometry. Clinical data were collected retrospectively from medical records. RESULTS: In univariate analysis, non-survivors as compared to survivors had higher age, lower arterial pressure, higher heart rate, and lower monocyte CD14 density. In multivariate analysis high age [relative mortality RR 1.05 (95% CI 1.01 to 1.08), p=0.016] and low CD 14 expression on monocytes [RR 7.49 (CI 1.63 to 34.33), p=0.01] remained predictive for the 28-day mortality. CONCLUSION: In patients with community-acquired infection, low on-admission level of monocyte CD14 is related to fatal outcome.
Subject(s)
CD11b Antigen/metabolism , Community-Acquired Infections/immunology , Community-Acquired Infections/mortality , Hospitalization , Lipopolysaccharide Receptors/metabolism , Phagocytes/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Patient Admission , Phagocytes/immunology , Survival Rate , Time FactorsABSTRACT
OBJECTIVE AND DESIGN: The effect of the granulocyte colony-stimulating factor filgrastim on systemic inflammation was investigated in a prospective, randomized, placebo-controlled, double-blind study in critically ill patients. SUBJECTS: 59 critically ill patients were recruited within 48 h of intubation due to ventilatory insufficiency. TREATMENT: Subcutaneous dosage of placebo or 300 microg filgrastim once daily. METHODS: Serum samples were collected at study entry, and 1 and 3 days after the start (Day1 and Day3, respectively). Levels of soluble E-selectin (sE-selectin) and interleukin (IL)-10 were determined by ELISA, and those of IL-6, and soluble IL-2 receptor (sIL-2R) by Immulite chemiluminescence immunoassay. RESULTS: The median sE-selectin level decreased by day 3 significantly in the control group but not in the filgrastim group. The difference in the change between the study groups was significant (p = 0.049). IL-10 levels decreased significantly in the filgrastim group, tended to decrease in controls (p = 0.052), and the difference in the change tended to be significant (p = 0.058). IL-6 levels decreased in both groups comparably. sIL-2R levels were elevated and stable. CONCLUSIONS: Filgrastim prolongs endothelial activation and possibly inhibits development of immune suppression mediated by IL-10.
Subject(s)
Critical Illness/therapy , Granulocyte Colony-Stimulating Factor/therapeutic use , Inflammation/immunology , Adult , Aged , Biomarkers , Blood Cell Count , Female , Humans , Inflammation/blood , Male , Middle AgedABSTRACT
An individual-based stochastic simulation model was constructed to study the epidemiology of Haemophilus influenzae type b (Hib) transmission, immunity and invasive disease. Embedded in a demographic model, the transmission model of Hib carriage employs the most important social mixing patterns with three types of contact sites (family, day-care group, and school class). The model includes immunity against invasive Hib disease, initiated and boosted by Hib carriage and cross-reactive bacterial encounters. The model reproduces the observed age patterns in Hib carriage and disease in Finland before large-scale use of the Hib conjugate vaccines. The model was used to investigate characteristics of Hib transmission. The analysis emphasizes transmission between children and adults in families while pointing out the importance of pre-school and school-aged children in maintaining Hib circulation. Carriage in these age groups is thus identified as being essential to target for sustained effects of interventions by vaccination.
Subject(s)
Disease Transmission, Infectious , Haemophilus Infections/prevention & control , Haemophilus Infections/transmission , Haemophilus influenzae type b/immunology , Models, Statistical , Adolescent , Adult , Child , Child, Preschool , Female , Finland/epidemiology , Haemophilus Infections/epidemiology , Haemophilus Infections/immunology , Haemophilus Vaccines , Haemophilus influenzae type b/pathogenicity , Humans , Infant , Infant, Newborn , Male , Middle Aged , Prevalence , VaccinationABSTRACT
We used a structured population model to study factors determining the magnitude of indirect protection in Haemophilus influenzae type b (Hib) vaccination. On a simulation platform mimicking the population of Finland, a Hib transmission and immunity model, including cross-reactive bacterial encounters, was formulated. Utilizing different vaccination coverages and vaccine types we could study how fast the incidence of Hib disease declined due to direct and indirect vaccination effects. With the Finnish vaccination schedule we could reproduce the observed disappearance of Hib cases. Our results show that an indirect effect was already significant with a relatively low vaccine coverage, even with a vaccine only partly reducing carriage acquisition. This suggests that the vaccination schedule and vaccine to be used should be chosen to result, in addition to immunological memory, in high antibody concentrations, sufficient to reduce carriage, the latter being the main factor behind successful elimination of transmission and disease.
Subject(s)
Haemophilus Infections/prevention & control , Haemophilus Vaccines , Haemophilus influenzae type b/immunology , Models, Statistical , Vaccination , Adolescent , Adult , Carrier State/immunology , Child , Child, Preschool , Female , Finland/epidemiology , Haemophilus Infections/epidemiology , Haemophilus Infections/immunology , Haemophilus Infections/transmission , Humans , Infant , Infant, Newborn , MaleABSTRACT
The aim of the present study was to determine whether the presence of an infectious focus or of fever alone can predict bloodstream infection and whether levels of C-reactive protein, procalcitonin, interleukin (IL)-6, IL-8, and soluble IL-2 receptor (sIL-2R) improve the diagnosis of community-acquired bloodstream infection. Markers of systemic inflammation were studied in 92 patients with community-acquired infection. On admission to hospital, 54 patients had an infectious focus, 25 had fever without an infectious focus, and 13 had neither. The presence of focus or fever predicted bloodstream infection (n=13 patients) with a sensitivity of 100% (95% confidence interval, 75-100), a specificity of 16% (95%CI, 9-26), a negative predictive value of 100% (95%CI, 75-100), and a positive predictive value of 16% (95%CI, 9-26). Positive predictive values of C-reactive protein, procalcitonin, IL-6, IL-8, and sIL-2R, all measured on admission, were also low (33-44%). Eight febrile patients in whom an infectious focus was found during a 3-day follow-up period had higher on-admission IL-6 (P=0.005) and sIL-2R (P=0.046) levels than did 17 febrile patients without an infectious focus. In conclusion, markers of systemic inflammation do not improve the diagnosis of community-acquired bloodstream infection; however, they may aid in identifying patients with fever due to occult infection.
Subject(s)
Bacteremia/diagnosis , Biomarkers/blood , Blood-Borne Pathogens/isolation & purification , Inflammation/diagnosis , Shock, Septic/diagnosis , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Bacteremia/epidemiology , Bacteremia/microbiology , C-Reactive Protein/analysis , Cohort Studies , Confidence Intervals , Critical Illness , Emergency Service, Hospital , Female , Finland , Humans , Interleukin-6/blood , Interleukin-8/blood , Male , Middle Aged , Predictive Value of Tests , Prognosis , ROC Curve , Receptors, Interleukin-2/blood , Risk Assessment , Sampling Studies , Sensitivity and Specificity , Shock, Septic/epidemiology , Shock, Septic/therapy , Survival RateABSTRACT
OBJECTIVE: To compare systemic inflammation in reactive arthritis (ReA), rheumatoid arthritis (RA), and sepsis using novel markers of systemic inflammation, and to study whether they are helpful in distinguishing between ReA and RA. METHODS: In 28 patients with acute ReA, 16 patients with early untreated RA, and 25 patients with blood culture-positive sepsis, phagocyte CD 11b expression was measured by flow cytometry, serum procalcitonin (PCT) levels by immunoluminometric assay, and soluble E-selectin (sE-selectin) levels by enzyme-linked immunosorbent assay (ELISA). RESULTS: Neutrophil and monocyte CD11b expression and serum levels of PCT and sE-selectin were higher in patients with sepsis than patients with ReA or RA, or in healthy subjects (all p < 0.01). They were comparable in healthy subjects, ReA, and RA. CONCLUSION: Patients with acute ReA and early RA have normal CD11b expression levels on phagocytes and normal PCT and sE-selectin levels in serum. Elevated levels suggest possible sepsis.
Subject(s)
Arthritis, Reactive/diagnosis , Arthritis, Rheumatoid/diagnosis , Bacteremia/diagnosis , Biomarkers/analysis , Inflammation Mediators/analysis , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Arthritis, Reactive/blood , Arthritis, Rheumatoid/blood , Bacteremia/blood , C-Reactive Protein/analysis , CD11 Antigens/analysis , Cohort Studies , E-Selectin/analysis , Female , Humans , Inflammation/blood , Inflammation/diagnosis , Male , Middle Aged , Probability , Prognosis , Prohibitins , Sensitivity and Specificity , Severity of Illness Index , Statistics, NonparametricABSTRACT
PURPOSE: To define the interrelationship between cost-of-illness, quality of life (QoL) and Parkinson's disease (PD) severity in a common patient management setting in Finland.Scope. Two hundred and sixty consecutive outpatients with idiopathic PD participated. UPDRS, motor fluctuations, QoL, and the use of health care resources were measured. Direct and indirect costs were calculated. CONCLUSIONS: There is a strong relationship between QoL or cost-of-illness on the one hand, and severity of PD on the other. Treatment policies capable of reducing or delaying motor fluctuations would be expected to increase QoL and reduce some of the economic burden of PD.
Subject(s)
Parkinson Disease/economics , Parkinson Disease/psychology , Quality of Life/psychology , Aged , Aged, 80 and over , Confidence Intervals , Female , Humans , Male , Middle Aged , Parkinson Disease/physiopathology , Statistics, NonparametricABSTRACT
BACKGROUND: Levosimendan, a novel calcium sensitiser, improves cardiac performance and symptoms without increasing oxygen consumption, and decreases the mortality of patients with low-output heart failure. AIMS: To estimate the cost-effectiveness of intravenous treatment with levosimendan compared with dobutamine in patients with severe low-output heart failure. METHODS: This economic evaluation was based on a European clinical trial (LIDO), in which 203 patients with severe heart failure randomly received a 24 h infusion with either levosimendan or dobutamine. Survival and resource utilisation data were collected for 6 months; survival was extrapolated assuming a mean additional lifetime of 3 years based on data from the Cooperative North Scandinavian Enalapril Survival Study trial. Costs were based on study drug usage and hospitalisation in the 6-month follow-up. A sensitivity analysis on dosage of drug and duration of survival was performed. RESULTS: The mean survival over 6 months was 157+/-52 days in the levosimendan group and 139+/-64 days in the dobutamine group (P<0.01). When extrapolated up to 3 years, the gain in life expectancy was estimated at 0.35 years (discounted at 3%). Levosimendan increased the mean cost per patient by 1108, which was entirely due to the cost of the study drug. The incremental cost per life-year saved (LYS) was 3205 at the European level; in the individual countries the cost per LYS ranged between 3091 and 3331. The result was robust in the sensitivity analysis. CONCLUSIONS: Although the patients in the levosimendan group were alive for more days and thus at risk of hospitalisation for longer, there was no increase in hospitalisation or hospitalisation costs with levosimendan treatment. The cost per LYS using levosimendan compares favourably with other cost-effectiveness analyses in cardiology.
Subject(s)
Cardiac Output, Low/drug therapy , Cardiac Output, Low/economics , Cardiotonic Agents/economics , Cardiotonic Agents/therapeutic use , Dobutamine/economics , Dobutamine/therapeutic use , Heart Failure/drug therapy , Heart Failure/economics , Hydrazones/economics , Hydrazones/therapeutic use , Pyridazines/economics , Pyridazines/therapeutic use , Aged , Cardiac Output, Low/epidemiology , Cost-Benefit Analysis/economics , Double-Blind Method , Europe/epidemiology , Female , Follow-Up Studies , Heart Failure/epidemiology , Humans , Infusions, Intravenous , Length of Stay/economics , Life Expectancy , Male , Middle Aged , Patient Admission/economics , Randomized Controlled Trials as Topic , Risk Factors , Sensitivity and Specificity , Severity of Illness Index , Simendan , Survival Analysis , Treatment OutcomeABSTRACT
Natural immunity to Haemophilus influenzae type b (Hib) invasive disease is based on antibodies arising in response to encounters with Hib or cross-reactive (CR) bacteria. The relative importance of Hib and CR contacts is unknown. We applied a statistical model to estimate the total rate of immunizing infections of Hib and CR prior to wide-scale vaccinations in Finland and the UK. The average rates of these contacts were 0.7 and 1.2 per year per child in Finland and the UK, respectively. Using a rough estimate of 0.1 Hib acquisitions per year per child in the UK based on carriage rates, the proportion of Hib among all immunizing contacts was in the order of 10%, suggesting that CR bacteria have a major role. In general, varying frequency of CR contacts may explain some differences in the pre-vaccination incidence and age-distribution of invasive disease in different countries.
Subject(s)
Antigens, Bacterial/immunology , Haemophilus Infections/epidemiology , Haemophilus influenzae type b/immunology , Age Factors , Antibodies, Bacterial/blood , Bacterial Capsules , Child , Child, Preschool , Cross Reactions , Finland/epidemiology , Haemophilus Infections/immunology , Haemophilus Vaccines/immunology , Humans , Immunity, Maternally-Acquired , Immunization , Infant , Infant, Newborn , Models, Statistical , Polysaccharides, Bacterial/immunology , United Kingdom/epidemiologyABSTRACT
The present paper describes a novel modification of polymerase chain reaction (PCR) for the detection of Streptococcus pneumoniae DNA in clinical specimens. PCR was based on the detection of a 209-base pair segment of the S. pneumoniae pneumolysin gene. For the demonstration of the amplification product, microwell hybridization with a Europium-labelled oligonucleotide probe complementary to a biotinylated strand of the PCR product was performed, and the presence of the PCR product was monitored by time-resolved fluorescence (TRF) of the Europium chelate. The sensitivity of the assay for purified S. pneumoniae DNA was 50 fg DNA corresponding to 20 genome equivalents of S. pneumoniae DNA. The efficiency of the hybridization step was monitored by using known amounts of synthetic target oligonucleotides as standards. Sensitivity of 3 x 10(8) molecules per individual reaction well was achieved with a 30-min attachment time and a 3-h hybridization time. Detection of PCR-amplified products by the microwell hybridization technique and TRF was compared to agarose gel electrophoresis in 50 middle ear fluid samples obtained from children with acute otitis media. The agarose gel and TRF detection methods identified all culture-positive samples, but both were also positive for 55% of the culture-negative samples. The results suggest that the detection of amplified PCR products by microwell hybridization using Europium-labelled oligonucleotides is a reliable method for the demonstration of the pneumolysin gene fragment. Furthermore, the method is suitable for automation and, thus, for testing high numbers of samples. The clinical significance of the PCR findings remains to be studied.
Subject(s)
DNA, Bacterial/analysis , Europium/chemistry , Fluorescent Dyes/chemistry , Nucleic Acid Hybridization/methods , Polymerase Chain Reaction/methods , Streptococcus pneumoniae/isolation & purification , Bacteriological Techniques/methods , Electrophoresis, Agar Gel , Evaluation Studies as Topic , Humans , Sensitivity and Specificity , Streptococcus pneumoniae/geneticsABSTRACT
BACKGROUND: Soluble E-selectin (sE-selectin) is a marker of activation of vascular endothelium. OBJECTIVE: To examine serum levels of sE-selectin in a cohort of 85 patients with early rheumatoid arthritis (RA) followed up for five years. METHODS: sE-selectin levels were assessed annually using an enzyme linked immunosorbent assay (ELISA) and related to simultaneously obtained clinical and laboratory measures. Joint inflammation was evaluated by active joint count, functional status by Health Assessment Questionnaire (HAQ), and radiographic findings in hands and feet by the Larsen method. Laboratory tests included serum C reactive protein (CRP) level, erythrocyte sedimentation rate, blood haemoglobin level, white blood cell count (WBC), and platelet count. Area under the curve (AUC) was calculated for each variable, and Jonckheere's test for ordered alternatives was applied to assess significance of association between sE-selectin AUC tertiles and other variables. Baseline sE-selectin tertiles were related to change in Larsen score and HAQ score at five years. Odds ratios (OR) with 95% confidence interval (CI) were calculated using univariate and multivariate logistic regression. RESULTS: sE-selectin levels were associated with CRP level (p=0.012), WBC (p=0.037), active joint count (p=0.019), progression of joint destruction (p=0.038), and HAQ score at five years (p=0.021), but not with extra-articular symptoms or comorbidity. Baseline sE-selectin levels in the third tertile predicted the HAQ score at five years (OR 4.18, 95% CI 1.15 to 15.22). sE-selectin levels of patients did not differ significantly from those of healthy control subjects. CONCLUSION: The degree of activation of vascular endothelium is associated with activity and outcome of early RA.
Subject(s)
Arthritis, Rheumatoid/blood , E-Selectin/blood , Adolescent , Adult , Aged , Biomarkers/blood , Blood Sedimentation , C-Reactive Protein/analysis , Enzyme-Linked Immunosorbent Assay , Female , Health Status , Humans , Leukocyte Count , Male , Middle Aged , Prospective Studies , Statistics as TopicABSTRACT
BACKGROUND: Close family and day-care contacts have been identified as risk factors for pneumococcal (Pnc) carriage. This study addresses the risk of Pnc carriage by infants 2 to 24 months of age in terms of simultaneous carriage of pneumococcus by family members. METHODS: Nasopharyngeal swabs were collected from 100 Finnish infants and their family members on 10 scheduled visits (when infant was 2, 3, 4, 5, 6, 9, 12, 15, 18 and 24 months of age). The 7 most common pneumococcal serogroups (4, 6, 9, 14, 18, 19, 23), also represented in the new heptavalent Pnc conjugate vaccine, were analyzed. Marginal logistic regression analyses were performed to assess the relative importance of different predictors for carriage. RESULTS: The carriage of the studied Pnc serogroups increased with age, being highest at the age of 18 months (28%). Among children older than 6 months of age, the strongest predictor of carriage was simultaneous carriage of the same serogroup by another family member (odds ratio, 3.8; 95% confidence interval, 2.1 to 6.9). At the age of 6 months or younger, carriage was rare and was not significantly associated with a family carriage. CONCLUSIONS: Young infants (< or =6 months old) were largely protected from pneumococcal carriage. After this age family transmission seemed very important despite the small family size. Contrary to some earlier studies communal day care was not associated with an increased risk of Pnc carriage. This could be partly because of the long parental leave in Finland and thus the late age of starting organized day care.
Subject(s)
Carrier State/epidemiology , Family Health , Pneumococcal Infections/epidemiology , Streptococcus pneumoniae/isolation & purification , Age Factors , Carrier State/transmission , Child Day Care Centers , Cohort Studies , Disease Transmission, Infectious , Family Characteristics , Female , Finland/epidemiology , Humans , Infant , Male , Nasopharynx/microbiology , Odds Ratio , Pneumococcal Infections/etiology , Pneumococcal Infections/transmission , Risk Factors , Serotyping , Streptococcus pneumoniae/classificationABSTRACT
BACKGROUND: Few data are available on cellular markers of systemic inflammation and immune suppression in early acute pancreatitis. The aim of this study was to describe the cellular immune inflammatory status of patients with acute pancreatitis in relation to development of organ failure. METHODS: Prospective study including 89 patients who presented within 72 h of onset of pain. Fifty-eight of them had mild disease (Grade I group), 19 had severe disease with no organ dysfunction (Grade II group) and 12 had severe disease with organ dysfunction (Grade III group). Serial blood samples were collected on admission and following 2 days. Phagocyte surface markers were analysed using flow cytometry. RESULTS: The proportion of HLA-DR-positive monocytes, a marker of immune suppression, and CD11b expression level on neutrophils and monocytes, a marker of systemic inflammation, were related to Grades I-III (P for trend <0.001). In Grade III patients, the proportion of HLA-DR-positive monocytes was low on presentation, or decreased rapidly during follow-up, whereas CD11b expression levels were persistently high. L-selectin and monocyte CD14 expression levels were not related to disease severity. CONCLUSIONS: Immune suppression develops early, rapidly and unexpectedly in patients with acute pancreatitis. Monitoring immune inflammatory status may provide the means by which to identify patients who benefit from biological response modifier therapy.